Magic Hour
You are here:  Home  >  Biotech  >  Current Article

Amgen stock up despite earnings miss for second quarter

By   /   Tuesday, July 30th, 2019  /   Comments Off on Amgen stock up despite earnings miss for second quarter

    Print       Email
A hike in Amgen’s full-year guidance sent shares edging up in after-hours trading July 30, despite a 3 percent dip in revenues and an earnings miss for its second quarter. The Thousand Oaks biotech reported $5.87 billion in revenues for the quarter ended June 30, down from $6.06 billion in the previous second quarter, but…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Carpinteria-based Procore Technologies moved up from No. 880 last year to No. 697 this year. (Nik Blaskovich)

Procore announces second recent acquisition

Read More →